首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1575767

蝴蝶针套装市场 - 2024-2031

Butterfly Needle Sets Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年，全球蝴蝶针套装市场达到2.2048亿美元，预计到2031年将达到3.7904亿美元，2024-2031年预测期间复合年增长率为7.1%。

蝴蝶针，也称为头皮静脉装置或翼式输液器，是一种用于从静脉抽取血液或透过静脉注射药物的工具。它由一根窄针、两个柔性翼、一根透明柔性管和一个连接器组成。

它广泛用于透过采集血液样本并提供快速小量输液来治疗挛缩患者和小儿。它主要用于静脉穿刺（也称为翼式输液器或蝴蝶装置）。

市场动态：

驱动程式和限制

慢性病盛行率增加

蝴蝶针被认为比普通针更精确且疼痛更少。随着越来越多的慢性病患者需要长期护理，医疗保健提供者更有可能使用设备来提高患者的舒适度并最大程度地减少担忧。人口老化更容易患慢性病，导致对蝴蝶针套件等医疗设备的需求增加，因为老年人经常需要定期进行医疗检查。

例如，根据美国疾病管制与预防中心2022年的报告，估计美国每10个成年人中约有6人患有慢性病，其中每10个成年人中就有4人患有两种以上慢性病。这增加了治疗期间所需程序对蝶形针组的需求。因此，上述因素预计将推动市场成长。

蝴蝶针成本高

与标准注射器和针头相比，蝶形针头通常更昂贵，特别是当涉及安全针头或预充式註射器等复杂功能时。这对于担心成本的消费者和医疗保健专业人士来说可能是一种威慑，尤其是在资源匮乏的地区。因此，它可能会阻碍市场的成长。

细分市场分析

全球蝶形针组市场根据量规类型、应用、最终用户和地区进行细分。

25G蝶形针领域预计将占据市场份额

25G蝶形针由于其相对于其他类型的优势和应用，预计将在市场份额中占据主导地位。与较小规格的针头（例如22G、21G）相比，25G 针头的直径较小，这使得它们更细，并且在插入过程中可能会引起较少的不适，特别是对于年轻人或静脉脆弱的患者。

由于它们的尺寸很小，它们在穿刺部位造成的组织损伤较少，从而促进更快的癒合，并可能减轻肿胀或瘀伤。静脉细弱的患者最好使用 25G 针头，因为较大的针头可能难以放置，甚至可能导致静脉塌陷。对于某些需要较慢血流管理的抽血或註射等操作，可能需要较小的尺寸。

由于尺寸减小，控制和精确度提高，手术过程中意外静脉损伤的可能性较小。因此，上述因素正在增加对25G蝶形针的需求，并预计将在预测期内保持该细分市场的主导地位。

市场地域占有率

北美预计将在蝴蝶针套市场份额中占据重要地位

预计北美将在市场成长中占据主导地位。该地区有多家医院、诊所和其他医疗机构，配备了最先进的工具和技术。由于这种强大的基础设施，市场正在不断增长，这导致基于蝴蝶针的医疗手术和治疗的使用增加。

癌症和糖尿病等慢性疾病在北美非常常见，这使得蝶形针在手术中的使用越来越普遍。例如，根据美国癌症协会估计，2024年美国将有约200万癌症病例。因此，上述因素预计将保持该地区在市场份额上的主导地位。

Butterfly needles are considered to be more precise and less painful than regular needles. As more patients with chronic diseases require long-term care, healthcare providers are more likely to use devices to improve patient comfort and minimize concern. The aging population is more vulnerable to chronic diseases, resulting in increased demand for medical devices such as butterfly needle sets, as elderly people often need regular medical tests.

For instance, according to the report by the Centers for Disease Control and Prevention in 2022, it is estimated that around 6 in 10 adults in the US are suffering from chronic diseases and among them 4 in 10 adults suffer from more than two chronic diseases at a time. This increases the need for butterfly needle sets for the procedures required during the treatment. Thus, the above factors are expected to drive the market growth.

High cost of the butterfly needles

Compared to standard syringes and needles, butterfly needles are often more costly, particularly when it comes to sophisticated features like safety needles or pre-filled syringes. This can be a deterrent for consumers and healthcare professionals who are concerned about costs, especially in areas with little resources. Thus, it can hinder the market growth.

Market Segment Analysis

The global butterfly needle sets market is segmented based on the gauge type, applications, end-users and region.

The 25G butterfly needles segment is expected to dominate the market share

25G butterfly needles are expected to hold the dominant position in the market share due to their advantages and applications over the other types. Compared to lesser gauge needles (e.g., 22G, 21G), 25G needles have a smaller diameter, which makes them thinner and may cause less discomfort during insertion, particularly for youngsters or patients with delicate veins.

Due to their tiny size, they cause less tissue damage at the puncture site, which promotes quicker healing and may lessen swelling or bruises. Patients with thin or frail veins are best served by 25G needles since bigger needles may be difficult to place or may even induce vein collapse. For operations like certain blood draws or injections that need slower blood flow management, a smaller size could be desirable.

Because of the reduced size, there is less chance of unintentional vein injury during operations due to improved control and precision. Thus, the above factors are increasing the demand for 25G butterfly needles and are expected to hold the segment in the dominant position in the forecast period.

Market Geographical Share

North America is expected to hold a significant position in the butterfly needle sets market share

North America is expected to hold a dominant position in the market growth. There are several hospitals, clinics, and other medical institutions in the region that are furnished with cutting-edge tools and technology. The market is growing because of this strong infrastructure, which leads to an increase in the use of butterfly needle-based medical operations and treatments.

Chronic diseases like cancer and diabetes are very common in North America, which makes the use of butterfly needles in procedures increasingly common. For instance, according to the American Cancer Society, it is estimated that there will be around 2 million cancer cases in the US in 2024. It is estimated that around 5,500 cancer cases will be diagnosed each day. Thus, the above factors are expected to hold the region in the dominant position in the market share.

Market Segmentation

By Gauge Type

21G Butterfly Needles

23G Butterfly Needles

25G Butterfly Needles

Others

By Applications

Delivery of Medications

IV Rehydration

Blood Transfusion

Others

By End-users

Hospitals

Blood Banks

Pathology Labs

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Nipro Corporation, Medline Industries, Terumo Corporation, Cardinal Health, Becton, Dickinson and Company, Kawasumi Laboratories America, ZIBO ECONST MEDICAL INSTRUMENT CO., LTD., Al Shifa Medical Products Co, Vitaimed Instrument Co., Ltd., McKesson Medical-Surgical Inc. among others.

Why Purchase the Report?

To visualize the global butterfly needle sets market segmentation based on the gauge type, applications, end-users, and region as well as understand key commercial assets and players.

identify commercial opportunities by analyzing trends and co-development.

excel data sheet with numerous data points of the butterfly needle sets market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global butterfly needle sets market report would provide approximately 55 tables, 58 figures and 180 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Gauge Type
3.2. Snippet by Applications
3.3. Snippet by End-users
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in the prevalence of chronic diseases
- 4.1.2. Restraints
  - 4.1.2.1. High cost of the butterfly needles
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Gauge Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 6.1.2. Market Attractiveness Index, By Gauge Type
6.2. 21G Butterfly Needles*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. 23G Butterfly Needles
6.4. 25G Butterfly Needles
6.5. Others

7. By Applications

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 7.1.2. Market Attractiveness Index, By Applications
7.2. Delivery of Medications*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. IV Rehydration
7.4. Blood Transfusion
7.5. Others

8. By End-users

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 8.1.2. Market Attractiveness Index, By End-users
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Blood Banks
8.4. Pathology Labs
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. Australia
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Nipro Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medline Industries
11.3. Terumo Corporation
11.4. Cardinal Health
11.5. Becton, Dickinson and Company
11.6. Kawasumi Laboratories America
11.7. ZIBO ECONST MEDICAL INSTRUMENT CO., LTD.
11.8. Al Shifa Medical Products Co
11.9. Vitaimed Instrument Co., Ltd.
11.10. McKesson Medical-Surgical Inc. (*LIST NOT EXHAUSTIVE)